openPR Logo
Press release

Deadline on March 16th coming up in Lawsuit for Investors in Penumbra, Inc. (NYSE: PEN)

03-01-2021 06:41 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on March 16, 2021 in the lawsuit for certain investors in Penumbra, Inc. (NYSE: PEN).

A Deadline is coming up on March 16, 2021 in the lawsuit for certain investors in Penumbra, Inc. (NYSE: PEN).

A deadline is coming up on March 16, 2021 in the lawsuit filed for certain investors of Penumbra, Inc. (NYSE: PEN) over alleged securities laws violations by Penumbra, Inc.

Investors who purchased shares of Penumbra, Inc. (NYSE: PEN) have certain options and there are strict and short deadlines running. Deadline: March 16, 2021. NYSE: PEN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Penumbra, Inc. (NYSE: PEN) common shares between August 3, 2020 and December 15, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 3, 2020 and December 15, 2020, the Defendants failed to disclose to investors that the Jet 7 Xtra Flex had known design defects that made it unsafe for its normal use, that Penumbra did not adequately address the risk of Jet 7 Xtra Flex causing serious injury and deaths, which had in fact already occurred, that the Jet 7 Xtra Flex was likely to be recalled due to its safety issues, and that as a result, Penumbra’s public statements as set forth above were materially false and misleading at all relevant times.

Those who purchased shares of Penumbra, Inc. (NYSE: PEN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on March 16th coming up in Lawsuit for Investors in Penumbra, Inc. (NYSE: PEN) here

News-ID: 2250352 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Penumbra

Investigation announced for Long-Term Investors in Penumbra, Inc. (NYSE: PEN)
Certain directors of Penumbra, Inc are under investigation concerning potential breaches of fiduciary duties. Investors who are current long term investors in Penumbra, Inc. (NYSE: PEN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: PEN stocks follows a lawsuit filed against Penumbra, Inc. over alleged securities laws violations.
Lawsuit filed for Investors in shares of Penumbra, Inc. (NYSE: PEN)
An investor, who purchased shares of Penumbra, Inc. (NYSE: PEN), filed a lawsuit over alleged violations of Federal Securities Laws by Penumbra, Inc. Investors who purchased shares of Penumbra, Inc. (NYSE: PEN) have certain options and for certain investors are short and strict deadlines running. Deadline: March 16, 2021. NYSE: PEN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Alameda, CA based Penumbra, Inc. designs, develops,
Investigation announced for Investors in shares of Penumbra, Inc. (NYSE: PEN)
Penumbra, Inc. is under investigation concerning potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Penumbra, Inc. (NYSE: PEN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Penumbra, Inc. regarding its business, its prospects and its operations were materially false and misleading at
Neurovascular Devices Market | Johnson & Johnson (Depuy), Medtronic, Stryker, Te …
Global Neurovascular Devices Market: Key Trends The rising number of ischemic strokes and brain aneurysm is one of the prominent factors expected to encourage the growth of the global neurovascular devices market in the next few years. In addition, a substantial rise in the demand for surgical processes with minimum invasion and technological developments in this field are anticipated to fuel the growth of the overall market in the coming
Interventional Neuroradiology Next Booming Segment with Key Players | Medtronic, …
HTF Market Intelligence released a new research report of 49 pages on title 'France Interventional Neuroradiology Market Outlook to 2025' with detailed analysis, forecast and strategies. The study covers key regions and important players such as Medtronic plc, Penumbra Inc, Stryker Corp Request a sample report @ https://www.htfmarketreport.com/sample-report/1452204-france-interventional-neuroradiology-market Summary HTF new report, France Interventional Neuroradiology Market Outlook to 2025, provides key market data on the France Interventional Neuroradiology market. The report provides
Occlusion Devices Market 2017 - 2025 : Stryker Corporation, Penumbra, Abbott, Ca …
Occlusion devises Market: Snapshot Occlusion devices are popularly used in cardiology for correcting the conditions caused by obstructions of blood flow in the coronary artery. These medical devices have emerged as a more effective option than anticoagulation therapy in treating the strokes caused by atrial fibrillation. For instance, of late, the market is witnessing promising avenues from the marked therapeutic efficacy of occlusion devices to reduce the risk of embolic stroke